Diagnostic Criterials of Liver Fibrosis Formation in Patients with Chronic viral Hepatititis C with Extrahepative Manifestations
Keywords:
Chronic hepatitis C, extrahepatic manifestations, cryoglobulinemic vasculitis, hemorrhagic vasculitis.Abstract
A comprehensive analysis was performed to assess the prevalence and significance of extrahepatic manifestations among patients diagnosed with chronic hepatitis C virus infection, particularly in the first group with cryoglobulinemia. The results revealed a markedly higher incidence of extrahepatic complications in these patients compared with those without circulating cryoglobulins. In addition, individuals in this group had more advanced stages of liver fibrosis, confirming the correlation between cryoglobulinemia and disease severity. The increased incidence of both liver fibrosis progression and extrahepatic manifestations suggests that the presence of cryoglobulins in the circulatory system serves as a critical aggravating factor that affects not only the clinical course of chronic hepatitis C but also its long-term outcome. These results highlight the need for increased clinical awareness and possibly individualized therapeutic strategies for patients with concomitant hepatitis C and cryoglobulinemia to mitigate disease complications and improve prognosis.
References
Akhmedova M.D. Determination of the effectiveness of hepatoprotectors in a short course of treatment in the complex therapy of chronic viral hepatitis B and C // Problems of biology and medicine. - Samarkand, 2014. - No. 3 (79). - P.83-87.
Baykova T.A., Lopatkina T.N. Diversity of extrahepatic manifestations of chronic viral hepatitis B and C, general principles of treatment // Therapeutic archive. - 2013. - Vol. 85, No. 4. - P.106-110.
Rakhimova V.Sh., Egamova I.N., Yarmukhamedova N.A. Joint syndrome as extrahepatic manifestations of chronic viral hepatitis C // Problems of biology and medicine. - 2020. No. 2. Vol. 118. - P.99-101.
Carrat F, Fontaine H, Dorival C. et all. French ANRS CO22 Hepathercohort. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study. //Lancet. 2019 № 393 Р. 1453-1464.
Douglas T. Dieterich, Joseph Ahn et al. A Simplified Algorithm for the Management of Hepatitis C Infection // Gastroenterology & Hepatology. – 2019 – Volume 15. – Issue 5. - Suppl. 3. – P. 3-10.
Galossi A, Guarisco R, Bellis L, Puoti C. Extrahepatic manifestations of chronic HCV infection. //J Gastrointestin Liver Dis. 2007; Vol 16 P.65-73.
Martinello M, Hajarizadeh B, Grebely J, Dore GJ, Matthews GV. Management of acute HCV infection in the era of direct-acting antiviral therapy. Nat Rev //Gastroenterol Hepatol. 2018 №15 Р. 412-424.
Obloqulov A.R., Oblokulova Z.I., Elmurodova A.A. et al. Virologic response in the treatment of infection with antiviral drugs. World Journal of Pharmaceutical Research 2020, ISSN 2277-7105. Pp 87-92. 8.
Romano C, Cuomo G, Ferrara R, Del Mastro A, Esposito S, Sellitto A, Adinolfi LE. Uncommon immune-mediated extrahepatic manifestations of HCV infection. //Expert Rev Clin Immunol. 2018 №14 Р. 1089-1099.
Spearman CW, Dusheiko GM, Hellard M, Sonderup M. Hepatitis C. //Lancet. 2019 № 394 Р. 1451-1466.
